Description
Tirzepatide is a dual-action GIP and GLP-1 receptor agonist studied for its effects on appetite, metabolism, blood-sugar regulation, and body-weight management. By activating two metabolic pathways, tirzepatide may help increase feelings of fullness, reduce hunger and food cravings, and support improved glucose control.
The 20 mg vial provides flexibility for individualized research protocols and gradual dose progression.
Key areas of research include:
- Appetite and craving regulation
- Weight-management support
- Glucose and insulin-response support
- Metabolic health
- Increased satiety and portion control
Vial Size: 20 mg
Form: Lyophilized powder
